reason report
price chang estim chang analysi
reiter invest rate increas former
price target per share follow
compani report notabl consensu fiscal result
establish favor revenu earn guidanc
importantli four compani busi segment realiz
consensu revenu growth increas oper margin
quarter compani guidanc reflect
absorpt million restructur relat revenu loss
remain confid compani abil either meet exceed
establish guidanc continu opinion
repres core hold within coverag univers
increas price increas former
price target per share revis price
target base multipl ev/ebitda non-
earn likewis price target support
dcf analysi assum termin multipl
wacc
chang estim revis former revenu
non-gaap earn estim reflect better
expect favor guidanc result
increas former revenu estim billion
billion moder non-gaap earn estim
addit increas former revenu
estim billion reduc former
non- earn estim per share earn
estim revis summar tabl left
constant currenc revenu growth guidanc rang
addit fx expect neutral fiscal year
result guidanc impli report annual revenu rang
billion billion yield non-gaap earn rang
per share deriv non-gaap earn guidanc
assum compani absorb million lost revenu
plan restructur compani effect tax rate
approxim addit establish
free cash flow guidanc million despit estim
million capital-expenditure includ million capit invest
relat expand compani global capac appli
base dublin ireland plc lead
provid steril washer hospit
pharmaceut compani research facil
compani also signific
line
consum well product surgic
set ast divis global leader end
import disclosur analyst certif page report access current disclosur stephen
inc cover compani client may refer
oper summari ste fiscal total revenu increas organ constant currenc basi
report million pre-cal consensu million four compani busi
segment out-pac consensu growth expect estim million stock took place relat
brexit concern compani adjust gross margin increas year year result increas
product favor price currenc partial off-set higher labor cost tariff ste adjust oper margin
increas year year result report non-gaap earn per dilut share
pre-cal consensu versu per dilut share fiscal oper period
segment overview oper period ste core healthcar product sale increas
million total revenu healthcar capit increas consum increas servic revenu
increas importantli healthcar capit backlog sequenti reflect strong start
compani backlog increas year year million healthcar specialti servic
post impress gain million compani appli steril technolog asst segment
grew million lastli life scienc increas million result increas
consum revenu million servic revenu increas million ste life scienc
capit backlog decreas million fiscal oper period compar million
balanc sheet oper period gener million oper cash flow incur
million capit expenditur result free cash flow million result compani exit
oper period million cash cash equival million total debt yield net debt
posit million equival net debt per dilut share
valuat summari share current valu revenu ebitda
non-gaap earn versu med tech industri peer trade averag like multipl
dividend maintain conjunct compani fiscal oper result board director
author quarterli dividend per common share payabl june sharehold record
close busi june
non-gaap ep revenu growth
consist demonstr
abil drive enhanc
oper leverag order realiz
earn growth outpac
million except per share data
compani document stephen inc estim
except per share data
revenu
sell gener administr
research develop
fiscal period
fiscal period
fiscal period
interest incom miscellan expens
less net incom attribut non-controlling interest
net incom attribut sharehold
sell gener administr
research develop
sell gener administr
research develop
compani file stephen estim
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
